Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 22, Pages E4482-E4491
Publisher
Proceedings of the National Academy of Sciences
Online
2017-05-16
DOI
10.1073/pnas.1620993114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
- (2016) Srinivas Malladi et al. CELL
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
- (2016) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes
- (2016) Hisham Mohammed et al. Nature Protocols
- FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
- (2016) Xiaoyong Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3
- (2016) Kamila M. Jozwik et al. Cell Reports
- Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
- (2016) Anuradha Illendula et al. EBioMedicine
- Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
- (2015) H. Taipaleenmaki et al. CANCER RESEARCH
- ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGF Signaling Pathway
- (2015) X.-Q. Li et al. CANCER RESEARCH
- Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion
- (2015) Gillian Browne et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
- (2015) Karine A. Cohen-Solal et al. Molecular Cancer
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- Treatment of Ebola
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma
- (2015) Saba Mohamed El-Gendi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer
- (2015) Zhengjun Yang et al. TUMOR BIOLOGY
- Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
- (2014) Gladys Morrison et al. BREAST CANCER RESEARCH AND TREATMENT
- Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer
- (2014) T. W. Owens et al. CANCER RESEARCH
- RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland
- (2014) L. McDonald et al. Disease Models & Mechanisms
- A rationale to target the SWI/SNF complex for cancer therapy
- (2014) Anja F. Hohmann et al. TRENDS IN GENETICS
- Pathview: an R/Bioconductor package for pathway-based data integration and visualization
- (2013) Weijun Luo et al. BIOINFORMATICS
- Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells
- (2013) Sandhya Pande et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX
- (2013) Otto Metzger-Filho et al. JOURNAL OF CLINICAL ONCOLOGY
- Target analysis by integration of transcriptome and ChIP-seq data with BETA
- (2013) Su Wang et al. Nature Protocols
- Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor
- (2013) Hisham Mohammed et al. Cell Reports
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells
- (2013) Deborah A Sanders et al. GENOME BIOLOGY
- Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
- (2012) Wenjun Guo et al. CELL
- GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility
- (2012) V. Theodorou et al. GENOME RESEARCH
- Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
- (2012) Linda Sofie Lindström et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Whole-genome analysis informs breast cancer response to aromatase inhibition
- (2012) Matthew J. Ellis et al. NATURE
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
- (2012) Caryn S. Ross-Innes et al. NATURE
- Identifying ChIP-seq enrichment using MACS
- (2012) Jianxing Feng et al. Nature Protocols
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
- (2012) Rita S. Mehta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should liver metastases of breast cancer be biopsied to improve treatment choice?
- (2011) G. Curigliano et al. ANNALS OF ONCOLOGY
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- RUNX1 and its understudied role in breast cancer
- (2011) Kevin A. Janes CELL CYCLE
- AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription
- (2011) Si Kee Tan et al. EMBO JOURNAL
- Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer
- (2011) Amit Agrawal et al. World Journal of Surgical Oncology
- Stability of estrogen receptor status in breast carcinoma
- (2010) Yun Gong et al. CANCER
- Estrogen-Dependent and Estrogen-Independent Mechanisms Contribute to AIB1-Mediated Tumor Formation
- (2010) M. I. Torres-Arzayus et al. CANCER RESEARCH
- Growth factor stimulation induces a distinct ER cistrome underlying breast cancer endocrine resistance
- (2010) M. Lupien et al. GENES & DEVELOPMENT
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide Analysis of Estrogen Receptor DNA Binding and Tethering Mechanisms Identifies Runx1 as a Novel Tethering Factor in Receptor-Mediated Transcriptional Activation
- (2010) J. D. Stender et al. MOLECULAR AND CELLULAR BIOLOGY
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- GAGE: generally applicable gene set enrichment for pathway analysis
- (2009) Weijun Luo et al. BMC BIOINFORMATICS
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model
- (2008) Hosein Kouros-Mehr et al. CANCER CELL
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- Modulation of Runx2 Activity by Estrogen Receptor-α: Implications for Osteoporosis and Breast Cancer
- (2008) Omar Khalid et al. ENDOCRINOLOGY
- Unique ERα Cistromes Control Cell Type-Specific Gene Regulation
- (2008) Susan A. Krum et al. MOLECULAR ENDOCRINOLOGY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now